Conference paper
ASSESSING THE CRITICAL ISSUES OF ATYPICAL ANTIPSYCHOTICS IN SCHIZOPHRENIC INPATIENTS
Francesco Franza
orcid.org/0000-0002-2263-3699
; Consultant of Neuropsychiatric Centre “Villa dei Pini”, Avellino, Italy
Barbara Solomita
; Psychotherapist, “Neamente Association”, Avellino, Italy
Gino Aldi
; Director Training and Research Psychotherapeutic Institute “Zetema”, Caserta, Italy
Gianfranco Del Buono
; Division Psychiatry, "S. Giovanni di Dio and Ruggi D'Aragona” Hospital, University Salerno, Salerno, Italy
Abstract
Antipsychotics are effective in reducing positive and disorganization symptoms of schizophrenia. Although SGAs initially all
were believed to be more efficacious and tolerable than FGAs, several data show that the SGAs are no more effective than FGAs. In clinical practice, frequent switching of antipsychotic medications is widespread for lack of efficacy, adverse side effects, and partial or not-compliance response. This study suggested that most clinically stable inpatients with schizophrenia maintain their remission states after being switched to another atypical antipsychotic; but that at the end (after 20 years) of the observation period of our study, 11.54% of the patients assumed again typical antipsychotics (haloperidol).
Keywords
schizophrenic spectrum; atypical antipsychotics; switching therapy
Hrčak ID:
263730
URI
Publication date:
15.6.2017.
Visits: 224 *